Global Artemisinin Combination Therapy Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Artemisinin Combination Therapy will have significant change from previous year. According to our (LP Information) latest study, the global Artemisinin Combination Therapy market size is USD million in 2022 from USD 340.4 million in 2021, with a change of % between 2021 and 2022. The global Artemisinin Combination Therapy market size will reach USD 478.3 million in 2028, growing at a CAGR of 5.0% over the analysis period.
The United States Artemisinin Combination Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Artemisinin Combination Therapy market, reaching US$ million by the year 2028. As for the Europe Artemisinin Combination Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Artemisinin Combination Therapy players cover KPC Pharmaceuticals, Shanghai Fosun Pharmaceutical Industrial Development, Sanofi, and Desano Holdings, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinin Combination Therapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
As the global economy mends, the 2021 growth of Artemisinin Combination Therapy will have significant change from previous year. According to our (LP Information) latest study, the global Artemisinin Combination Therapy market size is USD million in 2022 from USD 340.4 million in 2021, with a change of % between 2021 and 2022. The global Artemisinin Combination Therapy market size will reach USD 478.3 million in 2028, growing at a CAGR of 5.0% over the analysis period.
The United States Artemisinin Combination Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Artemisinin Combination Therapy market, reaching US$ million by the year 2028. As for the Europe Artemisinin Combination Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Artemisinin Combination Therapy players cover KPC Pharmaceuticals, Shanghai Fosun Pharmaceutical Industrial Development, Sanofi, and Desano Holdings, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Artemisinin Combination Therapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Artemether+Lumefantrine
- Artesunate+Amodiaquine
- Dihydroartemisinin+Piperaquine
- Artesunate+Mefloquine
- Artesunate+Sulfadoxine-Pyrimethamine
- Pyronaridine-Artesunate
- Other
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- KPC Pharmaceuticals
- Shanghai Fosun Pharmaceutical Industrial Development
- Sanofi
- Desano Holdings
- Calyx Chemicals and Pharmaceuticals
- Mylan
- Novartis
- Denk Pharma
- Hovid Berhad
- Ipca Laboratories
- Cipla
- Aspen Pharmacare Holdings
- Ajanta Pharma
- Guilin Pharmaceuticals
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artemisinin Combination Therapy Market Size 2017-2028
2.1.2 Artemisinin Combination Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Artemisinin Combination Therapy Segment by Type
2.2.1 Artemether+Lumefantrine
2.2.2 Artesunate+Amodiaquine
2.2.3 Dihydroartemisinin+Piperaquine
2.2.4 Artesunate+Mefloquine
2.2.5 Artesunate+Sulfadoxine-Pyrimethamine
2.2.6 Pyronaridine-Artesunate
2.2.7 Other
2.3 Artemisinin Combination Therapy Market Size by Type
2.3.1 Artemisinin Combination Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Artemisinin Combination Therapy Market Size Market Share by Type (2017-2022)
2.4 Artemisinin Combination Therapy Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Artemisinin Combination Therapy Market Size by Application
2.5.1 Artemisinin Combination Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Artemisinin Combination Therapy Market Size Market Share by Application (2017-2022)
3 ARTEMISININ COMBINATION THERAPY MARKET SIZE BY PLAYER
3.1 Artemisinin Combination Therapy Market Size Market Share by Players
3.1.1 Global Artemisinin Combination Therapy Revenue by Players (2020-2022)
3.1.2 Global Artemisinin Combination Therapy Revenue Market Share by Players (2020-2022)
3.2 Global Artemisinin Combination Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ARTEMISININ COMBINATION THERAPY BY REGIONS
4.1 Artemisinin Combination Therapy Market Size by Regions (2017-2022)
4.2 Americas Artemisinin Combination Therapy Market Size Growth (2017-2022)
4.3 APAC Artemisinin Combination Therapy Market Size Growth (2017-2022)
4.4 Europe Artemisinin Combination Therapy Market Size Growth (2017-2022)
4.5 Middle East & Africa Artemisinin Combination Therapy Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Artemisinin Combination Therapy Market Size by Country (2017-2022)
5.2 Americas Artemisinin Combination Therapy Market Size by Type (2017-2022)
5.3 Americas Artemisinin Combination Therapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisinin Combination Therapy Market Size by Region (2017-2022)
6.2 APAC Artemisinin Combination Therapy Market Size by Type (2017-2022)
6.3 APAC Artemisinin Combination Therapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Artemisinin Combination Therapy by Country (2017-2022)
7.2 Europe Artemisinin Combination Therapy Market Size by Type (2017-2022)
7.3 Europe Artemisinin Combination Therapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artemisinin Combination Therapy by Region (2017-2022)
8.2 Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2017-2022)
8.3 Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ARTEMISININ COMBINATION THERAPY MARKET FORECAST
10.1 Global Artemisinin Combination Therapy Forecast by Regions (2023-2028)
10.1.1 Global Artemisinin Combination Therapy Forecast by Regions (2023-2028)
10.1.2 Americas Artemisinin Combination Therapy Forecast
10.1.3 APAC Artemisinin Combination Therapy Forecast
10.1.4 Europe Artemisinin Combination Therapy Forecast
10.1.5 Middle East & Africa Artemisinin Combination Therapy Forecast
10.2 Americas Artemisinin Combination Therapy Forecast by Country (2023-2028)
10.2.1 United States Artemisinin Combination Therapy Market Forecast
10.2.2 Canada Artemisinin Combination Therapy Market Forecast
10.2.3 Mexico Artemisinin Combination Therapy Market Forecast
10.2.4 Brazil Artemisinin Combination Therapy Market Forecast
10.3 APAC Artemisinin Combination Therapy Forecast by Region (2023-2028)
10.3.1 China Artemisinin Combination Therapy Market Forecast
10.3.2 Japan Artemisinin Combination Therapy Market Forecast
10.3.3 Korea Artemisinin Combination Therapy Market Forecast
10.3.4 Southeast Asia Artemisinin Combination Therapy Market Forecast
10.3.5 India Artemisinin Combination Therapy Market Forecast
10.3.6 Australia Artemisinin Combination Therapy Market Forecast
10.4 Europe Artemisinin Combination Therapy Forecast by Country (2023-2028)
10.4.1 Germany Artemisinin Combination Therapy Market Forecast
10.4.2 France Artemisinin Combination Therapy Market Forecast
10.4.3 UK Artemisinin Combination Therapy Market Forecast
10.4.4 Italy Artemisinin Combination Therapy Market Forecast
10.4.5 Russia Artemisinin Combination Therapy Market Forecast
10.5 Middle East & Africa Artemisinin Combination Therapy Forecast by Region (2023-2028)
10.5.1 Egypt Artemisinin Combination Therapy Market Forecast
10.5.2 South Africa Artemisinin Combination Therapy Market Forecast
10.5.3 Israel Artemisinin Combination Therapy Market Forecast
10.5.4 Turkey Artemisinin Combination Therapy Market Forecast
10.5.5 GCC Countries Artemisinin Combination Therapy Market Forecast
10.6 Global Artemisinin Combination Therapy Forecast by Type (2023-2028)
10.7 Global Artemisinin Combination Therapy Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 KPC Pharmaceuticals
11.1.1 KPC Pharmaceuticals Company Information
11.1.2 KPC Pharmaceuticals Artemisinin Combination Therapy Product Offered
11.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 KPC Pharmaceuticals Main Business Overview
11.1.5 KPC Pharmaceuticals Latest Developments
11.2 Shanghai Fosun Pharmaceutical Industrial Development
11.2.1 Shanghai Fosun Pharmaceutical Industrial Development Company Information
11.2.2 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product Offered
11.2.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Shanghai Fosun Pharmaceutical Industrial Development Main Business Overview
11.2.5 Shanghai Fosun Pharmaceutical Industrial Development Latest Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Artemisinin Combination Therapy Product Offered
11.3.3 Sanofi Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Sanofi Main Business Overview
11.3.5 Sanofi Latest Developments
11.4 Desano Holdings
11.4.1 Desano Holdings Company Information
11.4.2 Desano Holdings Artemisinin Combination Therapy Product Offered
11.4.3 Desano Holdings Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Desano Holdings Main Business Overview
11.4.5 Desano Holdings Latest Developments
11.5 Calyx Chemicals and Pharmaceuticals
11.5.1 Calyx Chemicals and Pharmaceuticals Company Information
11.5.2 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product Offered
11.5.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Calyx Chemicals and Pharmaceuticals Main Business Overview
11.5.5 Calyx Chemicals and Pharmaceuticals Latest Developments
11.6 Mylan
11.6.1 Mylan Company Information
11.6.2 Mylan Artemisinin Combination Therapy Product Offered
11.6.3 Mylan Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Mylan Main Business Overview
11.6.5 Mylan Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Artemisinin Combination Therapy Product Offered
11.7.3 Novartis Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Denk Pharma
11.8.1 Denk Pharma Company Information
11.8.2 Denk Pharma Artemisinin Combination Therapy Product Offered
11.8.3 Denk Pharma Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Denk Pharma Main Business Overview
11.8.5 Denk Pharma Latest Developments
11.9 Hovid Berhad
11.9.1 Hovid Berhad Company Information
11.9.2 Hovid Berhad Artemisinin Combination Therapy Product Offered
11.9.3 Hovid Berhad Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Hovid Berhad Main Business Overview
11.9.5 Hovid Berhad Latest Developments
11.10 Ipca Laboratories
11.10.1 Ipca Laboratories Company Information
11.10.2 Ipca Laboratories Artemisinin Combination Therapy Product Offered
11.10.3 Ipca Laboratories Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Ipca Laboratories Main Business Overview
11.10.5 Ipca Laboratories Latest Developments
11.11 Cipla
11.11.1 Cipla Company Information
11.11.2 Cipla Artemisinin Combination Therapy Product Offered
11.11.3 Cipla Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Cipla Main Business Overview
11.11.5 Cipla Latest Developments
11.12 Aspen Pharmacare Holdings
11.12.1 Aspen Pharmacare Holdings Company Information
11.12.2 Aspen Pharmacare Holdings Artemisinin Combination Therapy Product Offered
11.12.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Aspen Pharmacare Holdings Main Business Overview
11.12.5 Aspen Pharmacare Holdings Latest Developments
11.13 Ajanta Pharma
11.13.1 Ajanta Pharma Company Information
11.13.2 Ajanta Pharma Artemisinin Combination Therapy Product Offered
11.13.3 Ajanta Pharma Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Ajanta Pharma Main Business Overview
11.13.5 Ajanta Pharma Latest Developments
11.14 Guilin Pharmaceuticals
11.14.1 Guilin Pharmaceuticals Company Information
11.14.2 Guilin Pharmaceuticals Artemisinin Combination Therapy Product Offered
11.14.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Guilin Pharmaceuticals Main Business Overview
11.14.5 Guilin Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Artemisinin Combination Therapy Market Size 2017-2028
2.1.2 Artemisinin Combination Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Artemisinin Combination Therapy Segment by Type
2.2.1 Artemether+Lumefantrine
2.2.2 Artesunate+Amodiaquine
2.2.3 Dihydroartemisinin+Piperaquine
2.2.4 Artesunate+Mefloquine
2.2.5 Artesunate+Sulfadoxine-Pyrimethamine
2.2.6 Pyronaridine-Artesunate
2.2.7 Other
2.3 Artemisinin Combination Therapy Market Size by Type
2.3.1 Artemisinin Combination Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Artemisinin Combination Therapy Market Size Market Share by Type (2017-2022)
2.4 Artemisinin Combination Therapy Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Artemisinin Combination Therapy Market Size by Application
2.5.1 Artemisinin Combination Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Artemisinin Combination Therapy Market Size Market Share by Application (2017-2022)
3 ARTEMISININ COMBINATION THERAPY MARKET SIZE BY PLAYER
3.1 Artemisinin Combination Therapy Market Size Market Share by Players
3.1.1 Global Artemisinin Combination Therapy Revenue by Players (2020-2022)
3.1.2 Global Artemisinin Combination Therapy Revenue Market Share by Players (2020-2022)
3.2 Global Artemisinin Combination Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ARTEMISININ COMBINATION THERAPY BY REGIONS
4.1 Artemisinin Combination Therapy Market Size by Regions (2017-2022)
4.2 Americas Artemisinin Combination Therapy Market Size Growth (2017-2022)
4.3 APAC Artemisinin Combination Therapy Market Size Growth (2017-2022)
4.4 Europe Artemisinin Combination Therapy Market Size Growth (2017-2022)
4.5 Middle East & Africa Artemisinin Combination Therapy Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Artemisinin Combination Therapy Market Size by Country (2017-2022)
5.2 Americas Artemisinin Combination Therapy Market Size by Type (2017-2022)
5.3 Americas Artemisinin Combination Therapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Artemisinin Combination Therapy Market Size by Region (2017-2022)
6.2 APAC Artemisinin Combination Therapy Market Size by Type (2017-2022)
6.3 APAC Artemisinin Combination Therapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Artemisinin Combination Therapy by Country (2017-2022)
7.2 Europe Artemisinin Combination Therapy Market Size by Type (2017-2022)
7.3 Europe Artemisinin Combination Therapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Artemisinin Combination Therapy by Region (2017-2022)
8.2 Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2017-2022)
8.3 Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL ARTEMISININ COMBINATION THERAPY MARKET FORECAST
10.1 Global Artemisinin Combination Therapy Forecast by Regions (2023-2028)
10.1.1 Global Artemisinin Combination Therapy Forecast by Regions (2023-2028)
10.1.2 Americas Artemisinin Combination Therapy Forecast
10.1.3 APAC Artemisinin Combination Therapy Forecast
10.1.4 Europe Artemisinin Combination Therapy Forecast
10.1.5 Middle East & Africa Artemisinin Combination Therapy Forecast
10.2 Americas Artemisinin Combination Therapy Forecast by Country (2023-2028)
10.2.1 United States Artemisinin Combination Therapy Market Forecast
10.2.2 Canada Artemisinin Combination Therapy Market Forecast
10.2.3 Mexico Artemisinin Combination Therapy Market Forecast
10.2.4 Brazil Artemisinin Combination Therapy Market Forecast
10.3 APAC Artemisinin Combination Therapy Forecast by Region (2023-2028)
10.3.1 China Artemisinin Combination Therapy Market Forecast
10.3.2 Japan Artemisinin Combination Therapy Market Forecast
10.3.3 Korea Artemisinin Combination Therapy Market Forecast
10.3.4 Southeast Asia Artemisinin Combination Therapy Market Forecast
10.3.5 India Artemisinin Combination Therapy Market Forecast
10.3.6 Australia Artemisinin Combination Therapy Market Forecast
10.4 Europe Artemisinin Combination Therapy Forecast by Country (2023-2028)
10.4.1 Germany Artemisinin Combination Therapy Market Forecast
10.4.2 France Artemisinin Combination Therapy Market Forecast
10.4.3 UK Artemisinin Combination Therapy Market Forecast
10.4.4 Italy Artemisinin Combination Therapy Market Forecast
10.4.5 Russia Artemisinin Combination Therapy Market Forecast
10.5 Middle East & Africa Artemisinin Combination Therapy Forecast by Region (2023-2028)
10.5.1 Egypt Artemisinin Combination Therapy Market Forecast
10.5.2 South Africa Artemisinin Combination Therapy Market Forecast
10.5.3 Israel Artemisinin Combination Therapy Market Forecast
10.5.4 Turkey Artemisinin Combination Therapy Market Forecast
10.5.5 GCC Countries Artemisinin Combination Therapy Market Forecast
10.6 Global Artemisinin Combination Therapy Forecast by Type (2023-2028)
10.7 Global Artemisinin Combination Therapy Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 KPC Pharmaceuticals
11.1.1 KPC Pharmaceuticals Company Information
11.1.2 KPC Pharmaceuticals Artemisinin Combination Therapy Product Offered
11.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 KPC Pharmaceuticals Main Business Overview
11.1.5 KPC Pharmaceuticals Latest Developments
11.2 Shanghai Fosun Pharmaceutical Industrial Development
11.2.1 Shanghai Fosun Pharmaceutical Industrial Development Company Information
11.2.2 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product Offered
11.2.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Shanghai Fosun Pharmaceutical Industrial Development Main Business Overview
11.2.5 Shanghai Fosun Pharmaceutical Industrial Development Latest Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Artemisinin Combination Therapy Product Offered
11.3.3 Sanofi Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Sanofi Main Business Overview
11.3.5 Sanofi Latest Developments
11.4 Desano Holdings
11.4.1 Desano Holdings Company Information
11.4.2 Desano Holdings Artemisinin Combination Therapy Product Offered
11.4.3 Desano Holdings Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Desano Holdings Main Business Overview
11.4.5 Desano Holdings Latest Developments
11.5 Calyx Chemicals and Pharmaceuticals
11.5.1 Calyx Chemicals and Pharmaceuticals Company Information
11.5.2 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product Offered
11.5.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Calyx Chemicals and Pharmaceuticals Main Business Overview
11.5.5 Calyx Chemicals and Pharmaceuticals Latest Developments
11.6 Mylan
11.6.1 Mylan Company Information
11.6.2 Mylan Artemisinin Combination Therapy Product Offered
11.6.3 Mylan Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Mylan Main Business Overview
11.6.5 Mylan Latest Developments
11.7 Novartis
11.7.1 Novartis Company Information
11.7.2 Novartis Artemisinin Combination Therapy Product Offered
11.7.3 Novartis Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Novartis Main Business Overview
11.7.5 Novartis Latest Developments
11.8 Denk Pharma
11.8.1 Denk Pharma Company Information
11.8.2 Denk Pharma Artemisinin Combination Therapy Product Offered
11.8.3 Denk Pharma Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Denk Pharma Main Business Overview
11.8.5 Denk Pharma Latest Developments
11.9 Hovid Berhad
11.9.1 Hovid Berhad Company Information
11.9.2 Hovid Berhad Artemisinin Combination Therapy Product Offered
11.9.3 Hovid Berhad Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Hovid Berhad Main Business Overview
11.9.5 Hovid Berhad Latest Developments
11.10 Ipca Laboratories
11.10.1 Ipca Laboratories Company Information
11.10.2 Ipca Laboratories Artemisinin Combination Therapy Product Offered
11.10.3 Ipca Laboratories Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Ipca Laboratories Main Business Overview
11.10.5 Ipca Laboratories Latest Developments
11.11 Cipla
11.11.1 Cipla Company Information
11.11.2 Cipla Artemisinin Combination Therapy Product Offered
11.11.3 Cipla Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Cipla Main Business Overview
11.11.5 Cipla Latest Developments
11.12 Aspen Pharmacare Holdings
11.12.1 Aspen Pharmacare Holdings Company Information
11.12.2 Aspen Pharmacare Holdings Artemisinin Combination Therapy Product Offered
11.12.3 Aspen Pharmacare Holdings Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Aspen Pharmacare Holdings Main Business Overview
11.12.5 Aspen Pharmacare Holdings Latest Developments
11.13 Ajanta Pharma
11.13.1 Ajanta Pharma Company Information
11.13.2 Ajanta Pharma Artemisinin Combination Therapy Product Offered
11.13.3 Ajanta Pharma Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Ajanta Pharma Main Business Overview
11.13.5 Ajanta Pharma Latest Developments
11.14 Guilin Pharmaceuticals
11.14.1 Guilin Pharmaceuticals Company Information
11.14.2 Guilin Pharmaceuticals Artemisinin Combination Therapy Product Offered
11.14.3 Guilin Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Guilin Pharmaceuticals Main Business Overview
11.14.5 Guilin Pharmaceuticals Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Artemisinin Combination Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Artemether+Lumefantrine
Table 3. Major Players of Artesunate+Amodiaquine
Table 4. Major Players of Dihydroartemisinin+Piperaquine
Table 5. Major Players of Artesunate+Mefloquine
Table 6. Major Players of Artesunate+Sulfadoxine-Pyrimethamine
Table 7. Major Players of Pyronaridine-Artesunate
Table 8. Major Players of Other
Table 9. Artemisinin Combination Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Artemisinin Combination Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 11. Global Artemisinin Combination Therapy Market Size Market Share by Type (2017-2022)
Table 12. Artemisinin Combination Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global Artemisinin Combination Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 14. Global Artemisinin Combination Therapy Market Size Market Share by Application (2017-2022)
Table 15. Global Artemisinin Combination Therapy Revenue by Players (2020-2022) & ($ Millions)
Table 16. Global Artemisinin Combination Therapy Revenue Market Share by Player (2020-2022)
Table 17. Artemisinin Combination Therapy Key Players Head office and Products Offered
Table 18. Artemisinin Combination Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Artemisinin Combination Therapy Market Size by Regions 2017-2022 & ($ Millions)
Table 22. Global Artemisinin Combination Therapy Market Size Market Share by Regions (2017-2022)
Table 23. Americas Artemisinin Combination Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 24. Americas Artemisinin Combination Therapy Market Size Market Share by Country (2017-2022)
Table 25. Americas Artemisinin Combination Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 26. Americas Artemisinin Combination Therapy Market Size Market Share by Type (2017-2022)
Table 27. Americas Artemisinin Combination Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 28. Americas Artemisinin Combination Therapy Market Size Market Share by Application (2017-2022)
Table 29. APAC Artemisinin Combination Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 30. APAC Artemisinin Combination Therapy Market Size Market Share by Region (2017-2022)
Table 31. APAC Artemisinin Combination Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 32. APAC Artemisinin Combination Therapy Market Size Market Share by Type (2017-2022)
Table 33. APAC Artemisinin Combination Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 34. APAC Artemisinin Combination Therapy Market Size Market Share by Application (2017-2022)
Table 35. Europe Artemisinin Combination Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 36. Europe Artemisinin Combination Therapy Market Size Market Share by Country (2017-2022)
Table 37. Europe Artemisinin Combination Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 38. Europe Artemisinin Combination Therapy Market Size Market Share by Type (2017-2022)
Table 39. Europe Artemisinin Combination Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 40. Europe Artemisinin Combination Therapy Market Size Market Share by Application (2017-2022)
Table 41. Middle East & Africa Artemisinin Combination Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Region (2017-2022)
Table 43. Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Type (2017-2022)
Table 45. Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 46. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Application (2017-2022)
Table 47. Key Market Drivers & Growth Opportunities of Artemisinin Combination Therapy
Table 48. Key Market Challenges & Risks of Artemisinin Combination Therapy
Table 49. Key Industry Trends of Artemisinin Combination Therapy
Table 50. Global Artemisinin Combination Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 51. Global Artemisinin Combination Therapy Market Size Market Share Forecast by Regions (2023-2028)
Table 52. Global Artemisinin Combination Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 53. Global Artemisinin Combination Therapy Market Size Market Share Forecast by Type (2023-2028)
Table 54. Global Artemisinin Combination Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 55. Global Artemisinin Combination Therapy Market Size Market Share Forecast by Application (2023-2028)
Table 56. KPC Pharmaceuticals Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 57. KPC Pharmaceuticals Artemisinin Combination Therapy Product Offered
Table 58. KPC Pharmaceuticals Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 59. KPC Pharmaceuticals Main Business
Table 60. KPC Pharmaceuticals Latest Developments
Table 61. Shanghai Fosun Pharmaceutical Industrial Development Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 62. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product Offered
Table 63. Shanghai Fosun Pharmaceutical Industrial Development Main Business
Table 64. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Shanghai Fosun Pharmaceutical Industrial Development Latest Developments
Table 66. Sanofi Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 67. Sanofi Artemisinin Combination Therapy Product Offered
Table 68. Sanofi Main Business
Table 69. Sanofi Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Sanofi Latest Developments
Table 71. Desano Holdings Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 72. Desano Holdings Artemisinin Combination Therapy Product Offered
Table 73. Desano Holdings Main Business
Table 74. Desano Holdings Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Desano Holdings Latest Developments
Table 76. Calyx Chemicals and Pharmaceuticals Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 77. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product Offered
Table 78. Calyx Chemicals and Pharmaceuticals Main Business
Table 79. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Calyx Chemicals and Pharmaceuticals Latest Developments
Table 81. Mylan Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 82. Mylan Artemisinin Combination Therapy Product Offered
Table 83. Mylan Main Business
Table 84. Mylan Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Mylan Latest Developments
Table 86. Novartis Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 87. Novartis Artemisinin Combination Therapy Product Offered
Table 88. Novartis Main Business
Table 89. Novartis Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Novartis Latest Developments
Table 91. Denk Pharma Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 92. Denk Pharma Artemisinin Combination Therapy Product Offered
Table 93. Denk Pharma Main Business
Table 94. Denk Pharma Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Denk Pharma Latest Developments
Table 96. Hovid Berhad Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 97. Hovid Berhad Artemisinin Combination Therapy Product Offered
Table 98. Hovid Berhad Main Business
Table 99. Hovid Berhad Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Hovid Berhad Latest Developments
Table 101. Ipca Laboratories Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 102. Ipca Laboratories Artemisinin Combination Therapy Product Offered
Table 103. Ipca Laboratories Main Business
Table 104. Ipca Laboratories Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Ipca Laboratories Latest Developments
Table 106. Cipla Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 107. Cipla Artemisinin Combination Therapy Product Offered
Table 108. Cipla Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 109. Cipla Main Business
Table 110. Cipla Latest Developments
Table 111. Aspen Pharmacare Holdings Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 112. Aspen Pharmacare Holdings Artemisinin Combination Therapy Product Offered
Table 113. Aspen Pharmacare Holdings Main Business
Table 114. Aspen Pharmacare Holdings Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Aspen Pharmacare Holdings Latest Developments
Table 116. Ajanta Pharma Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 117. Ajanta Pharma Artemisinin Combination Therapy Product Offered
Table 118. Ajanta Pharma Main Business
Table 119. Ajanta Pharma Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Ajanta Pharma Latest Developments
Table 121. Guilin Pharmaceuticals Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 122. Guilin Pharmaceuticals Artemisinin Combination Therapy Product Offered
Table 123. Guilin Pharmaceuticals Main Business
Table 124. Guilin Pharmaceuticals Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Guilin Pharmaceuticals Latest Developments
Table 1. Artemisinin Combination Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Artemether+Lumefantrine
Table 3. Major Players of Artesunate+Amodiaquine
Table 4. Major Players of Dihydroartemisinin+Piperaquine
Table 5. Major Players of Artesunate+Mefloquine
Table 6. Major Players of Artesunate+Sulfadoxine-Pyrimethamine
Table 7. Major Players of Pyronaridine-Artesunate
Table 8. Major Players of Other
Table 9. Artemisinin Combination Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Artemisinin Combination Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 11. Global Artemisinin Combination Therapy Market Size Market Share by Type (2017-2022)
Table 12. Artemisinin Combination Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global Artemisinin Combination Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 14. Global Artemisinin Combination Therapy Market Size Market Share by Application (2017-2022)
Table 15. Global Artemisinin Combination Therapy Revenue by Players (2020-2022) & ($ Millions)
Table 16. Global Artemisinin Combination Therapy Revenue Market Share by Player (2020-2022)
Table 17. Artemisinin Combination Therapy Key Players Head office and Products Offered
Table 18. Artemisinin Combination Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Artemisinin Combination Therapy Market Size by Regions 2017-2022 & ($ Millions)
Table 22. Global Artemisinin Combination Therapy Market Size Market Share by Regions (2017-2022)
Table 23. Americas Artemisinin Combination Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 24. Americas Artemisinin Combination Therapy Market Size Market Share by Country (2017-2022)
Table 25. Americas Artemisinin Combination Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 26. Americas Artemisinin Combination Therapy Market Size Market Share by Type (2017-2022)
Table 27. Americas Artemisinin Combination Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 28. Americas Artemisinin Combination Therapy Market Size Market Share by Application (2017-2022)
Table 29. APAC Artemisinin Combination Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 30. APAC Artemisinin Combination Therapy Market Size Market Share by Region (2017-2022)
Table 31. APAC Artemisinin Combination Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 32. APAC Artemisinin Combination Therapy Market Size Market Share by Type (2017-2022)
Table 33. APAC Artemisinin Combination Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 34. APAC Artemisinin Combination Therapy Market Size Market Share by Application (2017-2022)
Table 35. Europe Artemisinin Combination Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 36. Europe Artemisinin Combination Therapy Market Size Market Share by Country (2017-2022)
Table 37. Europe Artemisinin Combination Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 38. Europe Artemisinin Combination Therapy Market Size Market Share by Type (2017-2022)
Table 39. Europe Artemisinin Combination Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 40. Europe Artemisinin Combination Therapy Market Size Market Share by Application (2017-2022)
Table 41. Middle East & Africa Artemisinin Combination Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Region (2017-2022)
Table 43. Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Type (2017-2022)
Table 45. Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 46. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Application (2017-2022)
Table 47. Key Market Drivers & Growth Opportunities of Artemisinin Combination Therapy
Table 48. Key Market Challenges & Risks of Artemisinin Combination Therapy
Table 49. Key Industry Trends of Artemisinin Combination Therapy
Table 50. Global Artemisinin Combination Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 51. Global Artemisinin Combination Therapy Market Size Market Share Forecast by Regions (2023-2028)
Table 52. Global Artemisinin Combination Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 53. Global Artemisinin Combination Therapy Market Size Market Share Forecast by Type (2023-2028)
Table 54. Global Artemisinin Combination Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 55. Global Artemisinin Combination Therapy Market Size Market Share Forecast by Application (2023-2028)
Table 56. KPC Pharmaceuticals Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 57. KPC Pharmaceuticals Artemisinin Combination Therapy Product Offered
Table 58. KPC Pharmaceuticals Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 59. KPC Pharmaceuticals Main Business
Table 60. KPC Pharmaceuticals Latest Developments
Table 61. Shanghai Fosun Pharmaceutical Industrial Development Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 62. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Product Offered
Table 63. Shanghai Fosun Pharmaceutical Industrial Development Main Business
Table 64. Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Shanghai Fosun Pharmaceutical Industrial Development Latest Developments
Table 66. Sanofi Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 67. Sanofi Artemisinin Combination Therapy Product Offered
Table 68. Sanofi Main Business
Table 69. Sanofi Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Sanofi Latest Developments
Table 71. Desano Holdings Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 72. Desano Holdings Artemisinin Combination Therapy Product Offered
Table 73. Desano Holdings Main Business
Table 74. Desano Holdings Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Desano Holdings Latest Developments
Table 76. Calyx Chemicals and Pharmaceuticals Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 77. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Product Offered
Table 78. Calyx Chemicals and Pharmaceuticals Main Business
Table 79. Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Calyx Chemicals and Pharmaceuticals Latest Developments
Table 81. Mylan Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 82. Mylan Artemisinin Combination Therapy Product Offered
Table 83. Mylan Main Business
Table 84. Mylan Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Mylan Latest Developments
Table 86. Novartis Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 87. Novartis Artemisinin Combination Therapy Product Offered
Table 88. Novartis Main Business
Table 89. Novartis Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Novartis Latest Developments
Table 91. Denk Pharma Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 92. Denk Pharma Artemisinin Combination Therapy Product Offered
Table 93. Denk Pharma Main Business
Table 94. Denk Pharma Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Denk Pharma Latest Developments
Table 96. Hovid Berhad Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 97. Hovid Berhad Artemisinin Combination Therapy Product Offered
Table 98. Hovid Berhad Main Business
Table 99. Hovid Berhad Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Hovid Berhad Latest Developments
Table 101. Ipca Laboratories Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 102. Ipca Laboratories Artemisinin Combination Therapy Product Offered
Table 103. Ipca Laboratories Main Business
Table 104. Ipca Laboratories Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Ipca Laboratories Latest Developments
Table 106. Cipla Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 107. Cipla Artemisinin Combination Therapy Product Offered
Table 108. Cipla Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 109. Cipla Main Business
Table 110. Cipla Latest Developments
Table 111. Aspen Pharmacare Holdings Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 112. Aspen Pharmacare Holdings Artemisinin Combination Therapy Product Offered
Table 113. Aspen Pharmacare Holdings Main Business
Table 114. Aspen Pharmacare Holdings Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Aspen Pharmacare Holdings Latest Developments
Table 116. Ajanta Pharma Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 117. Ajanta Pharma Artemisinin Combination Therapy Product Offered
Table 118. Ajanta Pharma Main Business
Table 119. Ajanta Pharma Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Ajanta Pharma Latest Developments
Table 121. Guilin Pharmaceuticals Details, Company Type, Artemisinin Combination Therapy Area Served and Its Competitors
Table 122. Guilin Pharmaceuticals Artemisinin Combination Therapy Product Offered
Table 123. Guilin Pharmaceuticals Main Business
Table 124. Guilin Pharmaceuticals Artemisinin Combination Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. Guilin Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Artemisinin Combination Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artemisinin Combination Therapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Artemisinin Combination Therapy Market Size Market Share by Type in 2021
Figure 7. Artemisinin Combination Therapy in Hospital
Figure 8. Global Artemisinin Combination Therapy Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Artemisinin Combination Therapy in Clinic
Figure 10. Global Artemisinin Combination Therapy Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Artemisinin Combination Therapy in Other
Figure 12. Global Artemisinin Combination Therapy Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Artemisinin Combination Therapy Market Size Market Share by Application in 2021
Figure 14. Global Artemisinin Combination Therapy Revenue Market Share by Player in 2021
Figure 15. Global Artemisinin Combination Therapy Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Artemisinin Combination Therapy Market Size 2017-2022 ($ Millions)
Figure 17. APAC Artemisinin Combination Therapy Market Size 2017-2022 ($ Millions)
Figure 18. Europe Artemisinin Combination Therapy Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Artemisinin Combination Therapy Market Size 2017-2022 ($ Millions)
Figure 20. Americas Artemisinin Combination Therapy Value Market Share by Country in 2021
Figure 21. Americas Artemisinin Combination Therapy Consumption Market Share by Type in 2021
Figure 22. Americas Artemisinin Combination Therapy Market Size Market Share by Application in 2021
Figure 23. United States Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Artemisinin Combination Therapy Market Size Market Share by Region in 2021
Figure 28. APAC Artemisinin Combination Therapy Market Size Market Share by Application in 2021
Figure 29. China Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Artemisinin Combination Therapy Market Size Market Share by Country in 2021
Figure 36. Europe Artemisinin Combination Therapy Market Size Market Share by Type in 2021
Figure 37. Europe Artemisinin Combination Therapy Market Size Market Share by Application in 2021
Figure 38. Germany Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Application in 2021
Figure 46. Egypt Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 52. APAC Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 53. Europe Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 55. United States Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 56. Canada Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 59. China Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 60. Japan Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 61. Korea Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 63. India Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 64. Australia Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 65. Germany Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 66. France Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 67. UK Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 68. Italy Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 69. Russia Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 70. Spain Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 73. Israel Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 1. Artemisinin Combination Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Artemisinin Combination Therapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Artemisinin Combination Therapy Market Size Market Share by Type in 2021
Figure 7. Artemisinin Combination Therapy in Hospital
Figure 8. Global Artemisinin Combination Therapy Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Artemisinin Combination Therapy in Clinic
Figure 10. Global Artemisinin Combination Therapy Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Artemisinin Combination Therapy in Other
Figure 12. Global Artemisinin Combination Therapy Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Artemisinin Combination Therapy Market Size Market Share by Application in 2021
Figure 14. Global Artemisinin Combination Therapy Revenue Market Share by Player in 2021
Figure 15. Global Artemisinin Combination Therapy Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Artemisinin Combination Therapy Market Size 2017-2022 ($ Millions)
Figure 17. APAC Artemisinin Combination Therapy Market Size 2017-2022 ($ Millions)
Figure 18. Europe Artemisinin Combination Therapy Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Artemisinin Combination Therapy Market Size 2017-2022 ($ Millions)
Figure 20. Americas Artemisinin Combination Therapy Value Market Share by Country in 2021
Figure 21. Americas Artemisinin Combination Therapy Consumption Market Share by Type in 2021
Figure 22. Americas Artemisinin Combination Therapy Market Size Market Share by Application in 2021
Figure 23. United States Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Artemisinin Combination Therapy Market Size Market Share by Region in 2021
Figure 28. APAC Artemisinin Combination Therapy Market Size Market Share by Application in 2021
Figure 29. China Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Artemisinin Combination Therapy Market Size Market Share by Country in 2021
Figure 36. Europe Artemisinin Combination Therapy Market Size Market Share by Type in 2021
Figure 37. Europe Artemisinin Combination Therapy Market Size Market Share by Application in 2021
Figure 38. Germany Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Application in 2021
Figure 46. Egypt Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Artemisinin Combination Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 52. APAC Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 53. Europe Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 55. United States Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 56. Canada Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 59. China Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 60. Japan Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 61. Korea Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 63. India Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 64. Australia Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 65. Germany Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 66. France Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 67. UK Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 68. Italy Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 69. Russia Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 70. Spain Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 73. Israel Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Artemisinin Combination Therapy Market Size 2023-2028 ($ Millions)
